Publicaciones
-
Afia AB, Vila E, MacDowell KS, Ormazabal-Herrero A, Leza JC, Haro JM, Artuch-Iriberri R, Ramos B and Garcia-Bueno B.
Kynurenine pathway in post-mortem prefrontal cortex and cerebellum in schizophrenia: relationship with monoamines and symptomatology
JOURNAL OF NEUROINFLAMMATION . 18(1): 198-198. Nº de citas: 11
-
Calderon-Mediavilla M, Vila R, Dolz M, Butjosa A, Barajas A, del Cacho N, Sánchez Fernández B, Pardo M, Baños I, Usall J, GENIPE Group, PROFEP Group and Ochoa S.
Depressive symptoms and their relationship with negative and other psychotic symptoms in early onset psychosis.
EUROPEAN CHILD & ADOLESCENT PSYCHIATRY . 30(9): 1383-1390. Nº de citas: 13
-
González-Blanch C, Birulés-Muntané I, Esther Pousa Tomas, Maria Luisa Barrigon Estevez, López-Carrilero R, ESTHER LORENTE ROVIRA, Ayesa-Arriola R, Setien-Suero E, Barajas A, Grasa EM, Isabel Ruiz Delgado, González-Higueras F, Jordi Cid Colom and Ochoa S.
Moderators of cognitive insight outcome in metacognitive training for first-episode psychosis
JOURNAL OF PSYCHIATRIC RESEARCH . 141: 104-110. Nº de citas: 3
-
Brebion G, Nuñez C, Lombardini F, Carl Senior, Sánchez Laforga AM, Siddi S, Usall J and Stephan-Otto C.
Subclinical depression and anxiety impact verbal memory functioning differently in men and women -an fMRI study
JOURNAL OF PSYCHIATRIC RESEARCH . 140: 308-315. Nº de citas: 5
-
Casado-Ortega A, Vila R, Butjosa A, del Cacho N, Serra C, Marina Esteban Sanjusto, Diago M, Muñoz D, Pardo M and Usall J.
Social cognition and its relationship with sociodemographic, clinical, and psychosocial variables in first-episode psychosis
PSYCHIATRY RESEARCH . 302: 114040-114040. Nº de citas: 5
-
Pardo M, Matalí JL, Sivoli J, Vila R, Butjosa A, Dolz M, Sánchez Fernández B, Barajas A, del Cacho N, Baños I, Ochoa S and Usall J.
Early onset psychosis and cannabis use: Prevalence, clinical presentation and influence of daily use.
Asian Journal of Psychiatry . 62: 102714-102714. Nº de citas: 11
-
Bernardo M, Amoretti S, Cuesta MJ, Parellada M, Mezquida G, González-Pinto A, Bergé D, Lobo A, Aguilar EJ, Usall J, Corripio I, Bobes J, Rodríguez-Jiménez R, Sarró S, Contreras F, Ibáñez Á, Gutiérrez M, Micó JA and 2EPs Group.
The prevention of relapses in first episodes of schizophrenia: The 2EPs Project, background, rationale and study design
Spanish journal of psychiatry and mental health . 14(3): 164-176. Nº de citas: 11
-
Castells X, Ramon M, Cunill R, Olivé C and Serrano D.
Relationship Between Treatment Duration and Efficacy of Pharmacological Treatment for ADHD: A Meta-Analysis and Meta-Regression of 87 Randomized Controlled Clinical Trials.
JOURNAL OF ATTENTION DISORDERS . 25(10): 1352-1361. Nº de citas: 9
-
Diez-Quevedo C, Iglesias M, Giralt-López M, Rangil T, Sanagustin D, Moreira M, López-Ramentol M, Ibáñez-Caparrós A, Lorán ME, Bustos-Cardona T, Menéndez-Cuiñas I, Mundo-Cid P, Blanco-Presas L, de Pablo J and Cuevas-Esteban J.
Mental disorders, psychopharmacological treatments, and mortality in 2150 COVID-19 Spanish inpatients.
ACTA PSYCHIATRICA SCANDINAVICA . 143(6): 526-534. Nº de citas: 40
-
Huerta-Ramos ME, Ferrer-Quintero M, Gómez-Benito J, González-Higueras F, Cuadras-Palleja D, Del Rey-Mejías AL, Usall J and Ochoa S.
Translation and validation of Baron Cohen’s face test in a general population from Spain.
ACTAS ESPANOLAS DE PSIQUIATRIA . 49(3): 106-113. Nº de citas: 12